Clinical Trial Update: Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating talabostat in combination with temozolomide or carboplatin in pediatric patients with relapsed or refractory brain tumors and other sol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Childhood Germ Cell Tumor
• Kidney Cancer
• Liver Cancer
• Neuroblastoma
• Ovarian Cancer
• Sarcoma
• Unspecified Childhood Solid Tumor

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Talabostat (talabostat)
• Temozolomide (Temozolomide)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 | Status: COMPLETED